DR. AUTRY: Before we get started in this morning's agenda, let me just say that the board met for a few minutes last night and again this morning to try and DR. AUTRY: Thank you. DR. AUTRY: Thank you. DR. AUTRY: Again, anything that you don't get on the record, by all means do submit it in writing. DR. AUTRY: Thank you. DR. AUTRY: Again, please feel free to submit the rest of that for the record. DR. AUTRY: I might just make one comment about DR. AUTRY: She may be a recovering bureaucrat, but she has lost none of her speaking abilities. DR. AUTRY: Joseph Manno. DR. AUTRY: Thank you, Mr. Manno. DR. AUTRY: Thanks, Ken. DR. AUTRY: Next we have Howard Taylor. DR. AUTRY: Thank you, Mr. Taylor. DR. AUTRY: Thank you, Mr. Bost. DR. AUTRY: Thank you. DR. AUTRY: You guys are amazing the way you are staying on time today. DR. AUTRY: Thank you, Mr. Othman. DR. AUTRY: Thank you. DR. AUTRY: With that, let's not only give Donna a break, but let's all take a break for 15 minutes, and be back here at a 10:15 a.m. DR. AUTRY: Before I go into how we are going to run the rest of this morning, we have a late arriving comment, which is signed DRZ Management. DR. JONES: I would just reiterate Dr. Autry's earlier comments about our desire for additional data. DR. AUTRY: Originally I was thinking about giving each respondent five minutes. DR. AUTRY: Thank you, Dr. Baumgartner. DR. AUTRY: You can always tell somebody that does I would like to put a little historical perspective to where I see the board and Dr. Autry's responsibilities today versus where we were in 1985. DR. AUTRY: One serious comment, and then I will digress for a moment and tell you a little story. DR. AUTRY: Okay, anybody from laboratory urine testing want to comment? DR. AUTRY: Okay, I think we have covered the core areas. DR. AUTRY: Okay, saliva. DR. AUTRY: Okay, on-site? DR. AUTRY: Okay, sweat? DR. AUTRY: Okay, laboratory urine testing? DR. AUTRY: Dr. Sachs, you wanted to make a DR. AUTRY: Thank you. Saliva, any additional comments or concerns? PARTICIPANT: Don't beg. DR. AUTRY: How about on-site? Additional DR. AUTRY: Any comments from laboratory urine Dr. Autry in his opening remarks mentioned who the coordinators were for each of alternative matrices and whatever technologies were represented. May I ask that information that each and every one of you wish to contribute and get to the board come through Dr. Autry as director of this board, as chair of this board, or me, as executive secretary of this board. Our mailing address, should you not know it: Dr. Joseph Autry or Dr. Donna Bush at the Division of Workplace Programs, CSAP, abbreviation for Center for Substance Abuse Prevention, SAMHSA, our parent organization. Dr. Autry made reference to a meeting of the board When we have made requests for submission of items from the presenters or from the public to go through me or Dr. Autry, we will pass them onto the board. DR. AUTRY: Having heard the lunch alarm go off a few minutes ago, and have seeded our time beyond that, I'm going to suggest that we break for lunch, come back at 1:15 p.m. A F T E R N O O N S E S S I O N (1:20 p.m.) DR. AUTRY: What I thought we might do this DR. AUTRY: I am reminded of Will Roger's statement that there are two things you ought never watch being made. DR. AUTRY: Thank you. DR. AUTRY: Thank you. Other comments, questions? So I'm very pleased to have been a part of this process, and I applaud Dr. Autry and his colleagues for allowing this to occur, and I hope to see a lot more of it. DR. AUTRY: All of you have to remember one of DR. AUTRY: I might add to that, one thing that might be helpful to the board is when articles or additional information come in, if you could identify either in a cover note on the margin what section or what issue this seems to address from your perspective, it will make it a lot easier as we are plowing through the pages and pages and pages of paper if we know hey, yes, this goes with the section on internal quality control or on interpreting or whatever, or on both, whatever it happens to be. As a board member and as an individual I want to thank Dr. Autry's staff for putting this together. DR. AUTRY: Let me make one comment, and then I DR. AUTRY: So asking the coordinators and the DR. AUTRY: That is a point well taken. Now as the different matrices of the door walked into the potential workplace drug testing, and I would to know perhaps from this group, or probably specifically from you Dr. Autry what is the procedure involved from this point on in order to make these types of tests become an accepted legal being? DR. AUTRY: Let me talk a little bit about the DR. AUTRY: That will be part of the comments. I don't want to read myself in The Washington Post as Autry gets this wrong. We have a running joke my family. My son, who is now 23 and I have had this going since he was about 16. He says, "Well, Dad, you didn't make The Post this morning. You're doing pretty good."

Joseph Autry, M.D. Board Certified Psychiatrist; Senior Consultant, Veterans Administration; Former Acting Director, U.S. Substance Abuse and Mental Health Services Administration; Former Director, Office of Workplace Initiatives, U.S. Substance Abuse and Mental Health Services Administration.

"There is no typical abuser," says Joseph Autry, MD, of the US Substance Abuse and Mental Health Services Administration, commenting on studies showing how widespread pill addiction has become.

"There is no typical abuser," says Joseph Autry, MD, acting administrator of the US Substance Abuse and Mental Health Services Administration, commenting on studies that show how widespread this problem has become.

"We use DAWN to help pinpoint regional drug epidemics in the making and prepare communities to address the problems," said Joseph H. Autry III, M.D. acting SAMHSA Administrator.